Furthermore, given its distinct mechanism of action, BRP could be explored as a complementary therapy alongside existing weight loss medications, such as GLP-1 receptor agonists
Semaglutide (Ozempic, Wegovy) is a GLP-1 receptor agonist that reduces appetite hormonally, slows gastric emptying, and produces 1520% body weight reduction in clinical trials even without structured dietary intervention
cDNAs of tissues total RNA were synthesized using a PrimerScript TM RT reagent Kit with a gDNA Eraser (Perfect Real Time)(Takara, Japan) by S1000 TM Thermal Cycler (Bio-Rad, USA)
As we age, or when exposed to pollution, UV radiation, stress and poor lifestyle habits, glutathione levels may decline
Ozempic and Wegovy are not compounded